Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer
Triple-negative breast cancers are heterogeneous, poorly prognostic, and metastatic malignancies that result in a high risk of death for patients. Targeted therapy for triple-negative breast cancer has been extremely challenging due to the lack of expression of estrogen receptor, progesterone recept...
Enregistré dans:
Auteurs principaux: | Wenjie Zhao, Jinhua Liu, Yaqun Li, Zichao Chen, Dongmei Qi, Zhen Zhang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a534846f23ce4e4e9c63b82abe30376a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Establishment and validation of an individualized macrophage-related gene signature to predict overall survival in patients with triple negative breast cancer
par: Peng Su, et autres
Publié: (2021) -
Current advances in biomarkers for targeted therapy in triple-negative breast cancer
par: Fleisher B, et autres
Publié: (2016) -
Antiangiogenic therapy for breast cancer with triple negative phenotype
par: Inna P. Ganshina, et autres
Publié: (2021) -
Molecular-Genetic Portrait of Breast Cancer with Triple Negative Phenotype
par: Marina K. Ibragimova, et autres
Publié: (2021) -
Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel–cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines
par: Ye J, et autres
Publié: (2016)